[A Modified Lentivirus-Based Reporter for Magnetic Separation of Cancer Stem Cells]

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Cancer stem cells (CSCs) are a key driver of tumor malignancy and therapeutic resistance.
• Targeting CSCs is crucial for developing effective treatments, particularly for aggressive cancers.
• Accurate identification of CSCs remains a significant challenge in cancer research.

Purpose of the Study:

• To modify and validate a lentivirus-based reporter system (SORE6) for direct identification and isolation of CSCs.
• To assess the utility of the modified reporter in triple-negative breast cancer (TNBC) cell lines.
• To confirm the stem cell marker status of isolated cells by evaluating NANOG expression.

Main Methods:

• Development of a modified lentivirus-based reporter system to detect SOX2 and OCT4 expression.
• Transduction of HCC1806 and MDA-MB-453 TNBC cell lines with the reporter system.
• Immunomagnetic separation to isolate SOX2(+)/OCT4(+) cell populations.
• Analysis of NANOG protein content in isolated cell fractions via quantitative assays.

Main Results:

• The modified reporter system successfully identified and enabled the isolation of SOX2(+)/OCT4(+) cells in TNBC lines.
• Isolated SOX2(+)/OCT4(+) cell populations exhibited increased NANOG protein expression.
• The reporter system demonstrated suitability for studying CSC subsets.

Conclusions:

• The modified SORE6 reporter system provides a viable method for identifying and isolating CSCs expressing SOX2 and OCT4.
• This tool facilitates further research into the biology and therapeutic targeting of CSCs in TNBC.
• The validated reporter system holds promise for advancing targeted antitumor therapies.